Sign in to continue:

Saturday, July 25th, 2026

Category: Hong Kong Corporate News

LongBio Pharma Announces Phase III Success of LP-003 for Seasonal Allergic Rhinitis in China

LongBio Pharma Announces Positive Phase III Results for LP-0...

HashKey Holdings Announces HKD100 Million On-Market Share Repurchase Plan

HashKey Holdings Limited Announces HKD100 Million On-Market ...

Ascentage Pharma Announces Trustee Purchase of Shares for 2022 RSU Scheme on June 11, 2026

Ascentage Pharma Group International Announces Trustee Purch...